Diamante Società Benefit srl
- Biotech or pharma, therapeutic R&D
Diamante is a female-led biotech company pioneering a novel approach to autoimmune disease therapy based on immune tolerance induction. Our proprietary plant molecular farming platform enables the sustainable and scalable production of biologics with superior safety profiles. We are developing a first-in-class candidate for rheumatoid arthritis with strong preclinical proof-of-concept. The company has raised €1M in equity and secured €3.5M in non-dilutive funding from the EIC Accelerator and Italian public sources. We operate our own GMP-ready facility and are preparing for IND-enabling studies. Diamante is seeking a lead investor for its €10M Series A round (Q4 2025), of which €7.5M is already committed.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}